Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 3/20 | 0.53 |
| ▸ | FAAH | O00519 | 11/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22018851 | 0.93 | PSMB5 (0.47) | PSMB5FAAHMEN1KMT2AGAA | |
| SCHEMBL22019573 | 0.92 | RECQL (0.47) | PSMB5FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL27175504 | 0.91 | PSMB5 (0.45) | PSMB5FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL29211213 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL7150166 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL29211204 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL7153526 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL30876484 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL29211215 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 | |
| SCHEMBL30876495 | 0.84 | FAAH (0.61) | FAAHMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102053-A1 | METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVES | IMMUNOGEN, INC. (US) | 2020-05-22 | — | — | WO | disclosed |